(NMR) Nomura Holdings - Ratings and Ratios
Financial Products, Investment Services, Securities, Bonds, Derivatives
NMR EPS (Earnings per Share)
NMR Revenue
Description: NMR Nomura Holdings
Nomura Holdings Inc ADR (NYSE:NMR) is a global financial services company providing a wide range of services to individuals, corporations, and institutions. Its business is diversified across three main segments: Wealth Management, Investment Management, and Wholesale, allowing it to cater to various client needs, from financial products and investment consultation to securities underwriting and financial advisory services.
From a strategic perspective, Nomuras diversified business model and global presence are key strengths. The companys ability to offer a broad spectrum of financial services positions it well to capitalize on various market opportunities. Its Wholesale segment, in particular, is a significant contributor, given its comprehensive suite of services, including sales and trading, underwriting, and financial advisory. Key Performance Indicators (KPIs) such as revenue growth, market share in specific financial services, and the ratio of recurring revenue to total revenue could provide valuable insights into Nomuras operational efficiency and competitiveness.
When evaluating Nomuras financial health, metrics like Return on Equity (RoE) of 9.87% indicate a reasonable level of profitability relative to shareholder equity. However, the Price-to-Earnings (P/E) ratio of 8.45 and Forward P/E of 16.08 suggest that the market currently views the stock as undervalued relative to its future earnings potential. This discrepancy could be due to various factors, including market sentiment, industry trends, or company-specific challenges. Analyzing the companys debt-to-equity ratio, interest coverage ratio, and other leverage metrics would offer a more comprehensive view of its financial stability.
From a valuation perspective, Nomuras Market Cap of $19.219 billion USD places it among the significant players in the Investment Banking & Brokerage sub-industry. The companys global footprint, with operations in various countries, adds to its valuation. Understanding the geographic distribution of its revenue and the associated risks could be crucial. Additionally, examining Nomuras dividend yield, payout ratio, and historical dividend growth rate could be insightful for income-focused investors.
Overall, Nomura Holdings Inc ADR presents a complex investment opportunity that requires a nuanced analysis of its business segments, financial performance, and market valuation. A deeper dive into its operational KPIs, financial ratios, and industry positioning is necessary to form a well-informed investment decision.
NMR Stock Overview
| Market Cap in USD | 21,139m |
| Sub-Industry | Investment Banking & Brokerage |
| IPO / Inception | 1961-10-01 |
NMR Stock Ratings
| Growth Rating | 82.9% |
| Fundamental | 59.9% |
| Dividend Rating | 56.2% |
| Return 12m vs S&P 500 | 25.1% |
| Analyst Rating | 3.0 of 5 |
NMR Dividends
| Dividend Yield 12m | 5.78% |
| Yield on Cost 5y | 9.72% |
| Annual Growth 5y | 0.99% |
| Payout Consistency | 84.9% |
| Payout Ratio | 45.5% |
NMR Growth Ratios
| Growth Correlation 3m | 92.3% |
| Growth Correlation 12m | 78.2% |
| Growth Correlation 5y | 49.9% |
| CAGR 5y | 35.63% |
| CAGR/Max DD 3y | 1.35 |
| CAGR/Mean DD 3y | 5.95 |
| Sharpe Ratio 12m | 1.25 |
| Alpha | 31.48 |
| Beta | 0.724 |
| Volatility | 28.00% |
| Current Volume | 520.5k |
| Average Volume 20d | 452.9k |
| Stop Loss | 7.2 (-4.1%) |
| Signal | 0.14 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (376.36b TTM) > 0 and > 6% of Revenue (6% = 269.20b TTM) |
| FCFTA -0.01 (>2.0%) and ΔFCFTA -2.28pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -588.7% (prev -671.9%; Δ 83.21pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.02 (>3.0%) and CFO -1047.68b <= Net Income 376.36b (YES >=105%, WARN >=100%) |
| Net Debt (-4983.23b) to EBITDA (3298.12b) ratio: -1.51 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.22 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (3.07b) change vs 12m ago -0.54% (target <= -2.0% for YES) |
| Gross Margin 39.51% (prev -19.99%; Δ 59.50pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 7.61% (prev 4.07%; Δ 3.55pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.19 (EBITDA TTM 3298.12b / Interest Expense TTM 2714.09b) >= 6 (WARN >= 3) |
Altman Z'' -2.45
| (A) -0.45 = (Total Current Assets 7403.86b - Total Current Liabilities 33817.75b) / Total Assets 58101.09b |
| (B) 0.03 = Retained Earnings (Balance) 1963.11b / Total Assets 58101.09b |
| (C) 0.05 = EBIT TTM 3236.47b / Avg Total Assets 58921.11b |
| (D) 0.05 = Book Value of Equity 2557.60b / Total Liabilities 54512.14b |
| Total Rating: -2.45 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 59.92
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield -2.54% = -1.27 |
| 3. FCF Margin -19.36% = -7.26 |
| 4. Debt/Equity 10.38 = -2.50 |
| 5. Debt/Ebitda 10.94 = -2.50 |
| 6. ROIC - WACC 10.98% = 12.50 |
| 7. RoE 10.90% = 0.91 |
| 8. Rev. Trend 89.60% = 4.48 |
| 9. Rev. CAGR 65.42% = 2.50 |
| 10. EPS Trend 82.25% = 2.06 |
| 11. EPS CAGR 95.17% = 2.50 |
What is the price of NMR shares?
Over the past week, the price has changed by +4.31%, over one month by +3.87%, over three months by +20.16% and over the past year by +48.87%.
Is Nomura Holdings a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NMR is around 9.05 USD . This means that NMR is currently undervalued and has a potential upside of +20.51% (Margin of Safety).
Is NMR a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the NMR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 7.1 | -5.7% |
| Analysts Target Price | 7.1 | -5.7% |
| ValueRay Target Price | 9.5 | 27% |
Last update: 2025-09-05 04:53
NMR Fundamental Data Overview
CCE Cash And Equivalents = 4983.23b JPY (last quarter)
P/E Trailing = 8.5181
P/E Forward = 16.0772
P/S = 0.0108
P/B = 0.8776
P/EG = 0.851
Beta = 0.565
Revenue TTM = 4486.68b JPY
EBIT TTM = 3236.47b JPY
EBITDA TTM = 3298.12b JPY
Long Term Debt = 14270.23b JPY (from longTermDebt, last quarter)
Short Term Debt = 21806.84b JPY (from shortTermDebt, last quarter)
Debt = 36077.07b JPY (Calculated: Short Term 21806.84b + Long Term 14270.23b)
Net Debt = -4983.23b JPY (from netDebt column, last quarter)
Enterprise Value = 34210.16b JPY (3116.32b + Debt 36077.07b - CCE 4983.23b)
Interest Coverage Ratio = 1.19 (Ebit TTM 3236.47b / Interest Expense TTM 2714.09b)
FCF Yield = -2.54% (FCF TTM -868.58b / Enterprise Value 34210.16b)
FCF Margin = -19.36% (FCF TTM -868.58b / Revenue TTM 4486.68b)
Net Margin = 8.39% (Net Income TTM 376.36b / Revenue TTM 4486.68b)
Gross Margin = 39.51% ((Revenue TTM 4486.68b - Cost of Revenue TTM 2714.09b) / Revenue TTM)
Tobins Q-Ratio = 13.38 (Enterprise Value 34210.16b / Book Value Of Equity 2557.60b)
Interest Expense / Debt = 1.76% (Interest Expense 633.27b / Debt 36077.07b)
Taxrate = 26.42% (124.71b / 471.96b)
NOPAT = 2381.28b (EBIT 3236.47b * (1 - 26.42%))
Current Ratio = 0.22 (Total Current Assets 7403.86b / Total Current Liabilities 33817.75b)
Debt / Equity = 10.38 (Debt 36077.07b / last Quarter total Stockholder Equity 3476.01b)
Debt / EBITDA = 10.94 (Net Debt -4983.23b / EBITDA 3298.12b)
Debt / FCF = -41.54 (Debt 36077.07b / FCF TTM -868.58b)
Total Stockholder Equity = 3454.40b (last 4 quarters mean)
RoA = 0.65% (Net Income 376.36b, Total Assets 58101.09b )
RoE = 10.90% (Net Income TTM 376.36b / Total Stockholder Equity 3454.40b)
RoCE = 18.26% (Ebit 3236.47b / (Equity 3454.40b + L.T.Debt 14270.23b))
RoIC = 12.86% (NOPAT 2381.28b / Invested Capital 18513.79b)
WACC = 1.88% (E(3116.32b)/V(39193.39b) * Re(8.68%)) + (D(36077.07b)/V(39193.39b) * Rd(1.76%) * (1-Tc(0.26)))
Shares Correlation 3-Years: -44.28 | Cagr: -0.08%
Discount Rate = 8.68% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -868.58b)
Revenue Correlation: 89.60 | Revenue CAGR: 65.42%
Rev Growth-of-Growth: 14.54
EPS Correlation: 82.25 | EPS CAGR: 95.17%
EPS Growth-of-Growth: 3.17
Additional Sources for NMR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle